首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 234 毫秒
1.

Background

Prion protein (PrP) alleles associated with scrapie susceptibility persist in many sheep populations even with high frequencies despite centuries of selection against them. This suggests that scrapie susceptibility alleles have a pleiotropic effect or are associated with fitness or other traits that have been subject to selection.

Methodology/Principal Findings

We genotyped all lambs in two scrapie-free Scottish Blackface sheep flocks for polymorphisms at codons 136, 154 and 171 of the PrP gene. We tested potential associations of the PrP genotype with lamb viability at birth and postnatal survival using a complementary log-log link function and a Weibull proportional hazard model, respectively. Here we show there is an association between PrP genotype, as defined by polymorphisms at codons 154 ad 171, and postnatal lamb survival in the absence of scrapie. Sheep carrying the wild-type ARQ allele have higher postnatal survival rates than sheep carrying the more scrapie-resistant alleles (ARR or AHQ).

Conclusion

The PrP genotypes associated with higher susceptibility to scrapie are associated with improved postnatal survival in the absence of the disease. This association helps to explain the existence, and in many instances the high frequency, of the ARQ allele in sheep populations.  相似文献   

2.
The potential spread of prion infectivity in secreta is a crucial concern for prion disease transmission. Here, serial protein misfolding cyclic amplification (sPMCA) allowed the detection of prions in milk from clinically affected animals as well as scrapie-exposed sheep at least 20 months before clinical onset of disease, irrespective of the immunohistochemical detection of protease-resistant PrPSc within lymphoreticular and central nervous system tissues. These data indicate the secretion of prions within milk during the early stages of disease progression and a role for milk in prion transmission. Furthermore, the application of sPMCA to milk samples offers a noninvasive methodology to detect scrapie during preclinical/subclinical disease.PrPSc, a disease-specific marker for prion diseases and the likely infectious agent, is widely distributed within the central nervous system (CNS) and lymphoreticular tissues (LRS) in ovine scrapie, human variant Creutzfeldt-Jakob disease (vCJD), and cervine chronic wasting disease (CWD) during both clinical and preclinical stages (4, 11, 25). Furthermore, while the LRS distribution of PrPSc is much more restricted in bovine spongiform encephalopathy (BSE), sheep experimentally infected with BSE display a PrPSc tissue distribution more akin to that of ovine scrapie (11).For rodent-adapted scrapie and cervine CWD, the disease agent is detected in excreta when animals are in the clinical stages of disease, a process likely to contribute to environmental reservoirs of infectivity and lateral disease transmission (5, 13, 21). Within an experimental rodent model, it has also been demonstrated that the shedding of PrPSc and concomitant infectivity in feces occurs during preclinical scrapie (21).Evidence now also demonstrates that milk provides a vehicle for the transmission for prion diseases. Scrapie-free lambs fed milk from clinical scrapie-affected ewes propagate PrPSc within their LRS (8). Additionally, a recent study using a transgenic mouse bioassay demonstrated the secretion of infectivity in milk from preclinical animals where scrapie infectivity was found in milk months before the onset of clinical signs in animals with an ARQ/VRQ PrP genotype (10). The presence of scrapie infectivity within milk was irrespective of mammary gland pathology or PrPSc accumulation, and these animals were estimated to have considerable accumulation of immunohistochemically (IHC) detectable PrPSc within the LRS at the time of sampling.Here, we applied serial protein misfolding cyclic amplification (sPMCA) to the in vitro detection of PrPSc within sheep milk (Fig. (Fig.1)1) (Table (Table11).Open in a separate windowFIG. 1.sPMCA analysis of ovine milk samples. Milk was clarified and seeded into brain homogenate from sheep unexposed to the scrapie agent. Samples underwent sPMCA, and products were digested with proteinase K before analysis of 10 μl of each sample. PrP was detected with monoclonal antibodies SHA31 and P4; molecular mass markers are indicated (kDa). Milk was sampled from animals not exposed to the scrapie agent (U), those displaying clinical signs of scrapie (C), or those exposed to a scrapie-positive farm environment but not displaying clinical disease (S). NS, non-seeded PMCA brain substrate subjected to identical sPMCA conditions at the same time as positive samples were analyzed. Samples from the four nonexposed animals were analyzed 18 to 20 times each by sPMCA. Samples from clinically affected or clinically normal scrapie-exposed animals were analyzed in triplicate. For this triplicate analysis of each sample, the sPMCA round at which samples became positive is indicated under the appropriate lane. n, negative at round 12. Each sample was PrPSc negative until the stated round and thereafter was positive.

TABLE 1.

Timeline of exposure of animals to a scrapie-positive farm environment, sample collection, and scrapie status
Animala (PrP genotypeb)Age at exposurecDays postexposure at lactationDays postlactation to clinical scrapiedClinical statusePrPSc detection at postmortemfPrPSc detection in milk (positive tests/total tests)g
1349/08 (VRQ/VRQ)Not exposedNAh,iNANegativeNegative0/20
K489 (VRQ/VRQ)Not exposedNAiNANegativeNA (still alive)0/18
0618/06 (VRQ/VRQ)Not exposedNAiNANegativeNegative0/20
1348/08 (VRQ/VRQ)Not exposedNAiNANegativeNegative0/20
0695/07 (VRQ/VRQ)Birth666-6800PositivePositive3/3
0334/07 (VRQ/VRQ)Birth661-6660PositivePositive3/3
0335/07 (VRQ/VRQ)Birth666-6740PositivePositive3/3
0350/07 (VRQ/VRQ)Birth663-6760PositivePositive3/3
0333/07 (VRQ/VRQ)Birth667-6750PositivePositive3/3
0142/07 (VRQ/VRQ)Birth665-6730PositivePositive3/3
0326/07 (VRQ/VRQ)Birth670-6760PositivePositive2/3
0199/07 (VRQ/VRQ)Birth6640PositivePositive2/3
0692/07 (ARQ/VRQ)∼480 days1,003>450NegativePositive2/3
0480/07 (ARQ/VRQ)∼480 days1,003>355NegativePositive3/3
0349/07 (ARQ/VRQ)∼480 days1,003>348NegativePositive3/3
0822/07 (ARQ/VRQ)Birth760>564NegativeNegative2/3
2295 (AHQ/VRQ)∼120 days1,376>621NegativeNegative3/3
3148 (ARR/VRQ)Birth1,288>621NegativeNA (still alive)2/3
1514 (ARR/VRQ)Unknown597>621NegativeNA (still alive)2/3
1518 (ARR/VRQ)Unknown597>621NegativeNA (still alive)1/3
1244 (ARR/VRQ)Birth1,130>621NegativeNA (still alive)3/3
Open in a separate windowaAll animal procedures were performed under Home Office (United Kingdom) and local ethical review committee approval and compliance with the Animal (Scientific Procedures) Act of 1986.bAmino acid residues at positions 136, 154, and 171 of the PRNP gene.cIntroduction into a scrapie-affected flock.dDays postlactation to postmortem or as of 12 December 2008 for animals that were still alive at the time this paper was written.eClinical disease usually included head tremors and pruritus with associated wool loss and nervousness. The indicated clinical status was applicable throughout lactation to either postmortem or as of 12 December 2008 for animals that were still alive at the time this paper was written.fPrPSc was analyzed by IHC, Western blot analysis, or enzyme-linked immunosorbent assay. All animals with a positive result contained PrPSc within both brain and lymphatic tissues.gsPMCA was used for PrPSc detection and the results are tallied within this column. Replica analysis of a single milk sample from each animal was carried out. For animals 0695/07, 0334/07, 0335/07, 0350/07, 0333/07, 0142/07, and 0326/07, multiple milk samples were collected during the lactation period indicated and multiple samples from an individual animal were pooled before analysis.hNA, not applicable.iNonexposed animals were 750 to 1,110 days old at lactation and where applicable were 1,200 to 1,650 days old at postmortem.PMCA was first described by Saborio and colleagues (20) and allows the amplification of minute quantities of PrPSc (18). In rodent scrapie models, this methodology has detected PrPSc in both blood (2, 18) and brain (22) material in the clinical and preclinical stages of disease as well as in urine excreted during clinical disease (14). This technique has recently been applied to the high-level amplification of PrPSc from natural hosts of prion diseases, including vCJD (7), CWD (9), and scrapie (23). Fresh ovine milk was obtained from individual sheep at least 7 days postpartum. Milk was collected from individual animals into sterile containers and stored on ice for shipping. Within 48 h of collection, milk samples were stored at −80°C. Colostrum was not analyzed. After thawing milk samples, samples from the same individual animal were pooled and EDTA, Nonidet P-40, and sodium deoxycholate were added to final concentrations of 50 mM, 0.5% (vol/vol), and 0.5% wt/vol, respectively. Samples (1 ml) were centrifuged for 10 min at 16,000 × g. After cooling on ice for 5 min, clarified milk supernatant was withdrawn from under the solidified fat layer.sPMCA was carried out as described by Thorne and Terry (23), who demonstrated that samples from a range of animals containing at least one VRQ PrP allele could be amplified by this technique. Clarified milk supernatant was diluted 1 in 10 into PMCA brain homogenate substrate (10% [wt/vol] brain homogenate from a VRQ/VRQ PrP genotype animal within 150 mM NaCl, 4 mM EDTA, pH 8.0, 1.0% [wt/vol] Triton X-100, and miniprotease inhibitor; Roche) to a final volume of 100 μl. Samples contained within sealed 0.2-ml PCR tubes were placed in a rack within an ultrasonicating water bath (model 3000; Misonix) that held the bottom of the tubes 0.4 cm above the sonicator horn. Water was added to the water bath up to the rack surface, immersing the sonicator horn. The water bath was held at 37°C, and sonications were performed for 40 s at 200 W, equivalent to 80% of the maximum power output of the machine. Sonications were repeated once every 30 min for 24 h (one PMCA round), after which the amplified samples were diluted 1 in 3 with PMCA substrate in a final volume of 100 μl and the sample was subjected to further rounds of PMCA. Twelve PMCA rounds were performed for each sample, a total of 576 sonications over 12 days. PMCA samples were digested with 50 μg/ml proteinase K for 1 h at 37°C before analysis of 10 μl of each sample by Western blotting using 12% (wt/vol) acrylamide NuPAGE precast Bis-Tris gels (as described in reference 15). All clinical scrapie-affected animals or those exposed to the scrapie agent were challenged by introduction into the Ripley flock (Veterinary Laboratories Agency, United Kingdom), where natural scrapie is endemic with a high incidence since 1996. Ryder and coworkers (17) reported that all animals with PrP genotypes VRQ/VRQ and ARQ/VRQ that were born into this flock developed scrapie, with incubation periods of 21 to 28 months and 28 to 39 months, respectively. When ARQ/VRQ animals were introduced into the flock at 6 to 26 months of age, 77% of the animals had subclinical scrapie 24 to 30 months later, as detected by IHC analysis of the LRS. Here, PrPSc was detected in the milk from clinically affected animals at a rate of 92% (24 analyses; triplicate analyses of samples from 8 animals) and from scrapie-exposed, clinically normal sheep at a rate of 78% (27 analyses; triplicate analyses of samples from 9 animals) (Fig. (Fig.1)1) (Table (Table1).1). All scrapie-exposed sheep, both clinically affected and clinically normal, tested positive for PrPSc in at least one sPMCA reaction. PrPSc was amplified from the milk of sheep with VRQ/VRQ, ARR/VRQ, ARQ/VRQ, and AHQ/VRQ PrP genotypes (Table (Table1).1). It required at least four to eight rounds of sPMCA to produce detectable PrPSc within a milk sample from each of the scrapie-exposed sheep (Fig. (Fig.1).1). Replica analysis of a pooled milk sample from each individual sheep occasionally demonstrated high variability in the round that samples became positive for PrPSc (Fig. (Fig.1);1); this result may indicate the presence of very low levels of PrPSc (19) and/or heterogeneity within milk samples. Analyses of ovine milk from a New Zealand-derived scrapie-free flock kept under strict biosecurity conditions (ADAS, United Kingdom) did not amplify PrPSc within 12 rounds of sPMCA (78 analyses; up to 20 replica analyses of samples from 4 animals). For each of the sPMCA analyses, both positive and negative samples were analyzed concurrently within the same run on the same sonicator. These data demonstrate that PrPSc amplified from samples from scrapie-exposed animals is not due to spontaneous PrPSc formation or cross-contamination between samples within the sPMCA procedure. It is of note that prions were shed within milk from clinically normal, scrapie-exposed animals with multiple PrP genotypes. The ARQ/VRQ genotype is indicative of a high level of disease penetrance and widespread preclinical PrPSc accumulation within the LRS system, whereas AHQ/VRQ and ARR/VRQ genotype animals typically have much lower disease penetrance (24) and LRS involvement (11). This indicates the secretion of prions within milk regardless of high-level PrPSc accumulation within the LRS and also the very likely detection of subclinical as well as preclinical disease in some of these animals.No clinical scrapie-affected animals displayed clinical mastitis, and PrPSc was not detected within mammary gland tissue from five sheep with clinical scrapie (Fig. (Fig.22 and data not shown). This is in agreement with the study by Lacroux et al. (10), indicating that while the accumulation of PrPSc within mammary gland tissue can occur, it is not a prerequisite for its deposition within milk. Here, postmortem detection of PrPSc was carried out by routine diagnosis using IHC and Western blot analysis of the obex. Exceptions were animals 1349/08 and 1348/08, where obex tissue was analyzed by Bio-Rad TeSeE enzyme-linked immunosorbent assay (Table (Table1).1). Postmortem IHC examination of palatine tonsil, ileal Peyer''s patches, medial retropharyngeal lymph node, and mesenteric lymph node tissue was also carried out. Scrapie-exposed animals were shown to secrete PrPSc within their milk irrespective of whether they could be confirmed as scrapie positive by postmortem immunoassay detection of PrPSc within the CNS and LRS (Table (Table1).1). This discrepancy in PrPSc detection may well reflect the greater sensitivity of sPMCA compared to immunoassay detection of PrPSc; these results also indicate that PrPSc is secreted during the early stages of disease progression. Scrapie-exposed animals had PrPSc detected within their milk at least 20 months prior to possible clinical onset of disease, and this was not apparently influenced by the PrP genotype.Open in a separate windowFIG. 2.Detection of protease-resistant PrPSc within CNS and mammary gland tissues of animals displaying clinical scrapie. Tissues were prepared as 10% or 40% (wt/vol) homogenates for spinal cord and mammary gland tissue, respectively, as described previously elsewhere (15). Native or proteinase K-digested homogenates (25 μg/ml; 1 h at 37°C) were analyzed as indicated. Protease-resistant PrPSc was readily detectable within spinal cord tissue (SC; lanes 1 to 2) but was not detectable within mammary gland samples (MG; lanes 3 to 6). Either 0.33 mg (0350/07) or 0.165 mg (0326/07 and 0344/07) of spinal cord tissue and 1.32 mg (lanes 3 and 4) and 6 mg (lane 5) of mammary gland tissue was analyzed per lane. Protease-resistant PrPSc was still undetectable from 20 mg of mammary gland tissue following precipitation with sodium phosphotungstic acid (25) prior to analysis (lane 6). PrPSc within scrapie-positive brain tissue (63 μg) was readily detected by this method after spiking into 20 mg of mammary gland homogenate (B, lane 7). Full-length and fragmented protease-sensitive PrPC was readily detected within mammary gland tissue (lane 3). Animal numbers are indicated. PrP was detected with monoclonal antibody SHA31; molecular mass markers are indicated (kDa).These data clearly demonstrate that the secretion of PrPSc within milk occurs in natural scrapie. There are several routes through which the prion protein could be secreted into milk. Evidence suggests that within ovine mammary gland tissue, PrPC is actively produced within epithelial cells, and its secretion is most likely by exocytosis and the apocrine secretion of fat globules (3). It is unknown whether PrPSc is produced within epithelial cells and secreted into milk through similar mechanisms. Alternative mechanisms are through vesicular transcytosis or paracellular transport of PrPSc from the blood. It is established that prion-infected animals harbor infectivity and PrPSc within the blood during preclinical disease (6, 18) and that blood components are secreted within milk, including cell types known to colocalize with PrPSc within ovine mammary glands (12).Results indicate the potential transmission of scrapie in the milk of infected sheep for a prolonged period prior to clinical onset. As well as ewe-to-lamb disease transmission, this process is also likely to contribute to lateral transmission, as lambs fed milk from clinically infected ewes were the source for the transmission of scrapie between lambs within the first few months after birth (8). It is unknown whether other prion diseases result in the secretion of prions within milk. CWD, vCJD, and experimental ovine BSE share similarities with scrapie in the tissue distribution of infectivity, and it seems plausible that an analogous secretion mechanism may occur. Given the extended preclinical stages and the purported importance of subclinical states for these diseases (16), such an outcome would have significant implications for the transmission of prion diseases from apparently healthy animals and humans.With regard to ovine milk and milk products, scrapie is not transmissible to humans, and to date there is no evidence of the natural occurrence of ovine BSE. As such, the reported findings do not indicate the likely introduction of zoonotic prions from sheep into the human food chain. Nevertheless, the presented data do indicate caution in the risk assessment associated with such foods. Also, it is unknown if analogous shedding of prions into milk occurs with bovine BSE; evidence from previous epidemiological and bioassay studies would suggest that such a scenario seems unlikely to cause clinical disease (1, 26). However, the present report demonstrates that prions are secreted within the milk of sheep with PrP genotypes not typically associated with LRS accumulation of PrPSc and that prions were secreted from animals devoid of IHC-detectable PrPSc within their LRS. Such PrPSc tissue distribution is similar to bovine BSE, and given the importance of bovine milk in the human diet, the potential presence of low levels of prions within bovine milk warrants further investigation.Finally, analyzing milk samples by sPMCA offers a methodology with a clear potential for the identification of clinically sick animals and those with preclinical/subclinical scrapie. Such a noninvasive live-animal assay has the potential to contribute to the epidemiological study, management, and control of prion diseases within farmed animals.  相似文献   

3.
Prions are misfolded proteins that are infectious and naturally transmitted, causing a fatal neurological disease in humans and animals. Prion shedding routes have been shown to be modified by inflammation in excretory organs, such as the kidney. Here, we show that sheep with scrapie and lentiviral mastitis secrete prions into the milk and infect nearly 90% of naïve suckling lambs. Thus, lentiviruses may enhance prion transmission, conceivably sustaining prion infections in flocks for generations. This study also indicates a risk of prion spread to sheep and potentially to other animals through dietary exposure to pooled sheep milk or milk products.Prion diseases have emerged globally as a significant threat to human and animal health. Recently, human-to-human spread of prions is believed to have occurred through blood transfusions (9, 12, 16), underscoring the importance of understanding possible transmission routes. PrPSc, a misfolded, aggregated form of the normal prion protein, PrPC, commonly accumulates in the follicles of lymphoid tissues, prior to entering the central nervous system (2, 11, 14). Inflammation can cause lymphoid follicles to form in other organs, such as liver and kidney, which leads to prion invasion of organs that are not typically prion permissive (1). In mice, prion infection in the inflamed kidney has the untoward consequence of prion excretion in urine (13). This finding, together with our report of sheep with PrPSc in the inflamed mammary gland (8), has raised concerns of prion secretion into milk.Here, we investigated whether PrPSc in the inflamed mammary gland leads to prion secretion in milk and infection of naïve lambs through suckling. Prion infectivity has been detected in the milk of sheep expressing a prion gene (Prnp) coding for VRQ/VRQ or VRQ/ARQ at polymorphic codons 136, 154, and 171 (3, 4). However, whether (i) sheep-to-lamb transmission of prions in milk leads to clinical prion disease or (ii) sheep with the common ARQ/ARQ Prnp genotype can infect lambs through milk is unknown. We induced a chronic lentiviral mastitis and inoculated ARQ/ARQ Sarda breed sheep with infectious prions. After 14 months, we bred the sheep and collected the milk. To avoid cross-contamination of newborn lambs, we fed the milk to imported known-naïve lambs and then monitored the lambs for signs of prion infection (Fig. (Fig.1A1A).Open in a separate windowFIG. 1.Sheep infected with prions and maedi-visna virus (MVV) develop lymphofollicular mastitis with PrPSc. (A) Experimental scheme. Sheep were inoculated with culture medium or MVV and were then orally exposed to scrapie prions and bred. Milk was collected near the time point that neurologic signs of scrapie developed and was fed to naïve lambs. The ratio of lambs with detectable PrPSc to lambs fed the indicated milk is shown for each experiment. (B) PrP immunohistochemistry assay of brain and tonsil from milk source sheep shows staining for PrPSc in the brainstem, particularly in the vagal nucleus (indicated by asterisks) and in the tonsillar follicles of scrapie-infected sheep (arrows). (C) Mammary gland (MG) of milk source sheep shows lymphoid follicles (arrowheads) with associated PrPSc (arrows) adjacent to milk ducts (md) in the MVV-inoculated sheep, whereas the medium-inoculated sheep had a histologically normal MG with no detectable PrPSc. Insets show a high magnification of follicles containing PrPSc. Scale bar = 100 μm; scale bar in inset = 25 μm. (D) Western blot analysis shows PrPSc detection in MG of sheep inoculated with MVV/scrapie agents but not in sheep inoculated with scrapie prions only. The sheep identification number is indicated for each lane. PK, proteinase K digested; pos. br, positive brain control; neg. br, negative brain control.To induce a chronic lymphofollicular mastitis, we exposed 7- to 10-day-old lambs (groups of 10) by intratracheal and intravenous routes to a common sheep lentivirus known as maedi-visna virus (MVV) or to cell culture medium only. To do this, lambs were inoculated with 3.5 ml intravenously and 0.5 ml intratracheally of MVV in culture supernatant containing 1.5 × 106 tissue culture infectious doses/ml of the “rapid/high” MVV strain 85/34 (5, 15). Twenty days later, all lambs were orally inoculated with 25 ml of 10% scrapie-infected brain homogenate from a pool of naturally infected Sarda sheep.We sequenced the entire Prnp gene and found that all lambs expressed the ARQ/ARQ Prnp genotype, indicating that the sheep should be susceptible to scrapie. As negative controls, 2 lambs of Prnp genotype ARR/ARR and ARQ/ARQ were mock inoculated with cell culture medium and healthy brain homogenate. All lambs originated from scrapie-free flocks that had been monitored for clinical scrapie cases for at least 3 years.All inoculated sheep were naturally bred to rams at 15 months postinoculation (p.i.) and produced lambs at 20 months p.i. Sheep developed early signs of scrapie just after the lambs were born. Milk from each sheep was manually collected and frozen daily.Eight of 10 MVV-and-scrapie (denoted MVV/scrapie)-inoculated sheep and 9 of 10 scrapie-inoculated sheep showed clinical signs of scrapie, with mean incubation periods of 22 ± 1.4 and 23 ± 1.5 months postinoculation, respectively, and were euthanized. There was no significant difference in incubation period between the groups (Student''s t test, P = 0.5), indicating that inflammation associated with the MVV infection does not accelerate prion disease. This finding is consistent with the results of previous studies that showed that chronic pancreatitis or nephritis did not affect the scrapie incubation period (1). Scrapie infection was confirmed postmortem by the detection of PrPSc in brain and lymphoid tissues by Western blot and immunohistochemistry assays (Fig. (Fig.1B).1B). Interestingly, scrapie did not develop in 3 sheep with a Prnp gene encoding a rare polymorphism at codon 176 (K), consistent with recent reports describing scrapie resistance for this genotype (10).Antibodies to MVV were detected in serum of all the MVV-inoculated sheep by indirect enzyme-linked immunosorbent assay (ELISA) (Elitest kit; Hyphen BioMed). Five of 8 MVV/scrapie-infected sheep (63%) showed a lymphofollicular mastitis (Fig. (Fig.1C),1C), and 3 had a diffuse interacinar lymphoid infiltrate. Of the 5 sheep with lymphofollicular mastitis, 4 had PrPSc deposits detectable by immunohistochemistry and Western blot assays (Fig. 1C and D), whereas no sheep with diffuse lymphoid infiltrates had detectable PrPSc. Surprisingly, 2 of 9 sheep inoculated only with scrapie also had lymphofollicular mastitis and anti-MVV antibodies, one of which had visible PrPSc deposits. MVV is a common pathogen in Europe, and it is possible that these sheep were infected from the dam. The remaining 7 scrapie-inoculated sheep had histologically normal mammary glands (Fig. (Fig.1C)1C) and no detectable PrPSc (Fig. (Fig.1D)1D) or anti-MVV antibodies.We selected the stored milk from the 4 MVV/scrapie-infected sheep with PrPSc in the mammary glands and from the 7 scrapie-infected sheep with histologically normal mammary glands. Milk samples from the early, middle, and late stages of lactation were pooled for each group. We imported naïve Cheviot lambs (n = 9) from flocks that originated from scrapie-free New Zealand and had been bred and housed under strict biosecurity containment in the United Kingdom to ensure that the lambs had not been exposed to scrapie. The Sarda lambs (n = 4) originated from a scrapie-free flock in Sardinia. We then fed pooled milk from MVV/scrapie-infected sheep to each of 8 naïve ARQ/ARQ lambs and from scrapie-infected sheep to 3 naïve ARQ/ARQ lambs ad libitum. Each lamb ingested a total volume of 1 to 2 liters over a total period of 3 days (Table (Table1).1). Two lambs were orally inoculated with brain homogenate pooled from the scrapie-infected milk donors as positive controls. Groups of lambs were housed in separate stalls and subjected to isolation conditions.

TABLE 1.

Genotype, breed, and PrPSc detection in lambs fed milk from MVV/scrapie- or scrapie-infected sheep
Lamb (dimorphisma)Milk source infected with:Amt of milk ingested (liters)BreedClinical signs presentPrPSc detected by WB/IHC in:
Time point postinoculation (mo)
BrainTonsil
951MVV/Scrapie1.2CheviotNo−/−−/−12
326 (127G/V)MVV/Scrapie1.9SardaNo−/−−/−28
328 (127G/V)MVV/Scrapie1.8SardaYes+/++/+28
327MVV/Scrapie1.4SardaYes+/++/+25
847MVV/Scrapie1.3CheviotYes+/++/+23
329MVV/Scrapie2.1SardaYes+/++/+25
843 (141F/L)MVV/Scrapie1.3CheviotNo+/++/+28
849 (141F/L)MVV/Scrapie1.8CheviotNo+/++/+29
953 (141F/L)Scrapie1.5CheviotNo−/−−/−28
956 (141F/L)Scrapie1.7CheviotNo−/−−/−28
957 (141F/L)Scrapie1.4CheviotNo−/−−/−28
Open in a separate windowaThe Prnp genotype of all lambs was ARQ/ARQ at codons 136, 154, and 171. Additional dimorphisms in other codons of Prnp are noted.Of the 8 lambs fed milk from MVV/scrapie-infected sheep, 1 was sacrificed early and 4 developed clinical signs of scrapie at 23 to 28 months p.i. (Table (Table1).1). The 3 remaining MVV/scrapie-exposed lambs and all control lambs were sacrificed between 28 and 29 months p.i. Both lambs orally inoculated with scrapie brain had PrPSc deposits detectable in the brain. The lamb from the MVV/scrapie group that was sacrificed early (12 months p.i.) had developed an intercurrent illness and had no biochemical or histologic evidence of scrapie infection. However, 6 of the 7 (86%) remaining lambs exposed to milk from the MVV/scrapie-infected dams had detectable PrPSc in the brain and lymphoid tissues (Fig. (Fig.2),2), indicating that infection from prion-laden milk was dependent on mammary gland inflammation. No lambs fed milk from the scrapie-only infected dams had detectable PrPSc. We considered that horizontal transmission of prions could have occurred within the MVV/scrapie-exposed lambs; however, Sardinian strains of sheep scrapie are not efficiently transmitted in ARQ/ARQ Sarda sheep, with a maximum recorded prevalence of 41% and an average prevalence of 13% (7).Open in a separate windowFIG. 2.Lambs developed prion infection through suckling milk from scrapie-infected sheep with mastitis. Brainstem and tonsil from lambs ingesting milk from MVV/scrapie- or scrapie-infected sheep were immunostained for PrP (A) or proteinase K digested (PK) and examined by Western blotting (B). The results show that only the lambs suckling the milk derived from MVV/scrapie-infected sheep accumulated PrPSc. The sheep identification number is indicated for each lane. scr+, scrapie-positive control; scr−, scrapie-negative control. Scale bars = 100 μm.Previous studies have found that the cellular fraction of milk harbors the most infectivity (4), and the higher leukocyte count in milk that occurs with mastitis could conceivably have increased the infectious prion titers in milk. Our studies in ARQ/ARQ sheep suggest that mammary gland inflammation is necessary for prion transmission through milk, although it remains possible that large milk volumes from sheep without mastitis would transmit prions to nursing lambs. Indeed, milk from VRQ/VRQ sheep without clinical mastitis was previously shown to transmit prion infection to the lambs, as evidenced by PrPSc deposits in lymphoid tissue biopsy specimens (3).Taken together, these findings demonstrate that the ingestion of as little as 1 to 2 liters of milk from sheep with scrapie and lymphofollicular mastitis can cause prion infection in ARQ/ARQ lambs at an attack rate of 86%. These data show that a common lentivirus can induce an inflammatory setting highly conducive for prion propagation and secretion in milk, although a role for the virus in transporting prions into the milk or stimulating PrPSc release from infected cells (6) cannot be excluded. Considering that MVV and other lentiviruses are endemic in sheep and goat populations worldwide, the possibility that lentiviruses have enabled prion transmission through milk and, ultimately, the propagation of scrapie through some flocks should be considered. Together with two other recent reports on infectious prions in sheep milk (3, 4), these studies indicate a risk of prion spread to sheep and, potentially, other animals through dietary exposure to sheep milk or milk products. World milk production contributes up to 13% of the protein supply for humans; thus, studies to determine the extent of infectious prions entering our global food supply would be worthwhile and important for accurate risk assessment.  相似文献   

4.
5.

Background

Most previous analyses of scrapie outbreaks have focused on flocks run by research institutes, which may not reflect the field situation. Within this study, we attempt to rectify this deficit by describing the epidemiological characteristics of 30 sheep flocks naturally-infected with classical scrapie, and by exploring possible underlying causes of variation in the characteristics between flocks, including flock-level prion protein (PrP) genotype profile. In total, the study involved PrP genotype data for nearly 8600 animals and over 400 scrapie cases.

Methodology/Principal Findings

We found that most scrapie cases were restricted to just two PrP genotypes (ARQ/VRQ and VRQ/VRQ), though two flocks had markedly different affected genotypes, despite having similar underlying genotype profiles to other flocks of the same breed; we identified differences amongst flocks in the age of cases of certain PrP genotypes; we found that the age-at-onset of clinical signs depended on peak incidence and flock type; we found evidence that purchasing infected animals is an important means of introducing scrapie to a flock; we found some evidence that flock-level PrP genotype profile and flock size account for variation in outbreak characteristics; identified seasonality in cases associated with lambing time in certain flocks; and we identified one case that was homozygous for phenylalanine at codon 141, a polymorphism associated with a very high risk of atypical scrapie, and 28 cases that were heterozygous at this codon.

Conclusions/Significance

This paper presents the largest study to date on commercially-run sheep flocks naturally-infected with classical scrapie, involving 30 study flocks, more than 400 scrapie cases and over 8500 PrP genotypes. We show that some of the observed variation in epidemiological characteristics between farms is related to differences in their PrP genotype profile; although much remains unexplained and may instead be attributed to the stochastic nature of scrapie dynamics.  相似文献   

6.
Genetic susceptibility to scrapie, a fatal disease of sheep and goats, is modulated by polymorphisms in the prion protein (PrP). Neither the frequency of the PrP genotypes nor their association with animal performance has been investigated in a large multibreed Irish sheep population. Scrapie genotypes were available on 16 416 animals; the breeds represented included purebred Belclare (733), Charollais (333), Suffolk (739), Texel (1 857), Vendeen (191), and crossbreds (12 563). Performance data on lambing, lamb and ewe performance as well as health traits were available. The association between alternative approaches of describing the PrP genotype (i.e. 15 individually called PrP genotypes, five genotype classes representing susceptibility to scrapie, or number of ARR haplotypes) and animal performance were quantified using animal linear mixed models. All 15 of the possible scrapie genotypes were detected, although the frequency differed by breed. The frequency of the five PrP haplotypes in the entire population were 0.70 (ARR), 0.15 (ARQ), 0.11 (ARH), 0.02 (AHQ) and 0.01 (VRQ); the most susceptible haplotype (VRQ) was only detected in purebred Texels and crossbreds. No association was detected between the PrP genotype of either the animal or dam and any of the lambing traits (i.e. lambing difficulty score, perinatal mortality and birth weight). With the exception of ultrasound muscle depth, no association between the PrP genotype and any of the lamb performance traits (i.e. lamb BW and carcass) was observed. Lambs carrying the category four PrP genotype (i.e. ARR/VRQ) had 1.20 (SE = 0.45) mm, 1.38 (SE = 0.12) mm, 1.47 (S = 0.25) mm shallower ultrasound muscle depth relative to lambs of the less susceptible scrapie categories of 1, 2, 3, respectively (P < 0.05). Nonetheless, no association between PrP genotype and lamb carcass conformation, the ultimate end goal of producers, was detected. Ewe litter size, body condition score or lameness did not differ by PrP genotype of the ewe (P > 0.05). For ewe mature BW, ARH/VRQ ewes differed from most other ewe PrP genotypes and were, on average, 3.79 (SE = 1.66) kg heavier than ARR/ARR genotype ewes. Lamb dag score differed by dam PrP genotype (P < 0.05), although the differences were small. Results from this study show that scrapie is segregating within the Irish sheep population, but the PrP genotype was not associated with most traits investigated and, where associations were detected, the biological significance was minimal. This suggests minimal impact of selection on PrP genotype on performance, at least for the traits investigated in the present study.  相似文献   

7.

Background

Cellular prion protein expression is essential for the development of transmissible spongiform encephalopathies (TSEs), and in sheep, genetic susceptibility to scrapie has been associated to PrP gene polymorphisms. To test the hypothetical linkage between PrP gene expression and genetic susceptibility, PrP mRNA levels were measured by real-time RT-PCR in six ovine tissues of animals with different genotypes.

Results

Previous to the PrP gene expression analysis the stability of several housekeeping (HK) genes was assessed in order to select the best ones for relative quantification. The normalisation of gene expression was carried out using a minimum of three HK genes in order to detect small expression differences more accurately than using a single control gene. The expression stability analysis of six HK genes showed a large tissue-associated variation reflecting the existence of tissue-specific factors. Thereby, a specific set of HK genes was required for an accurate normalisation of the PrP gene expression within each tissue. Statistical differences in the normalised PrP mRNA levels were found among the tissues, obtaining the highest expression level in obex, followed by ileum, lymph node, spleen, cerebellum and cerebrum. A tendency towards increased PrP mRNA levels and genetic susceptibility was observed in central nervous system. However, the results did not support the hypothesis that PrP mRNA levels vary between genotypes.

Conclusion

The results on PrP gene expression presented here provide valuable baseline data for future studies on scrapie pathogenesis. On the other hand, the results on stability data of several HK genes reported in this study could prove very useful in other gene expression studies carried out in these relevant ovine tissues.
  相似文献   

8.
To assess scrapie infectivity associated with caprine-origin tissues, bioassay can be performed using kids, lambs or transgenic mice expressing caprine or ovine prion (PRNP) alleles, but the incubation periods are fairly long. Although several classical ovine scrapie prion permissive cell lines with the ability to detect brain-derived scrapie prion have been available, no classical caprine scrapie permissive cell line is currently available. Therefore, the aims of this study were to generate a rabbit kidney epithelial cell line (RK13) stably expressing caprine wild-type PRNP (cpRK13) and then to assess permissiveness of cpRK13 cells to classical caprine scrapie prion propagation. The cpRK13 and plasmid control RK13 (pcRK13) cells were incubated with brain-derived classical caprine scrapie inocula prepared from goats or ovinized transgenic mice (Tg338, express ovine VRQ allele) infected with caprine scrapie. Significant PrPSc accumulation, which is indicative of scrapie prion propagation, was detected by TSE ELISA and immunohistochemistry in cpRK13 cells inoculated with classical caprine scrapie inocula. Western blot analysis revealed the typical proteinase K-resistant 3 PrPres isoforms in the caprine scrapie prion inoculated cpRK13 cell lysate. Importantly, PrPSc accumulation was not detected in similarly inoculated pcRK13 cells, whether by TSE ELISA, immunohistochemistry, or western blot. These findings suggest that caprine scrapie prions can be propagated in cpRK13 cells, thus this cell line may be a useful tool for the assessment of classical caprine prions in the brain tissues of goats.  相似文献   

9.
Sheep scrapie is a transmissible spongiform encephalopathy that can be transmitted horizontally. The prion protein gene (PRNP) profoundly influences the susceptibility of sheep to the scrapie agent and the tissue levels and distribution of PrPSc in affected sheep. The purpose of this study was to compare the survival time and PrPSc tissue distribution in sheep with highly resistant and highly susceptible PRNP genotypes after intracranial inoculation of the agent of scrapie. Five sheep each of genotype VRQ/VRQ, VRQ/ARR or ARQ/ARR were inoculated. Sheep were euthanized when clinical signs of scrapie became severe. Clinical signs, microscopic lesions, and western blot profiles were uniform across genotypes and consistent with manifestations of classical scrapie. Mean survival time differences were associated with the 171 polymorphic site with VRQ/VRQ sheep surviving 18 months, whereas VRQ/ARR and ARQ/ARR sheep survived 60 and 56 months, respectively. Labeling of PrPSc by immunohistochemistry revealed similar accumulations in central nervous system tissues regardless of host genotype. Immunoreactivity for PrPSc in lymphoid tissue was consistently abundant in VRQ/VRQ, present but confined to tonsil or retropharyngeal lymph node in 4/5 VRQ/ARR, and totally absent in ARQ/ARR sheep. The results of this study demonstrate the susceptibility of sheep with the ARQ/ARR genotype to scrapie by the intracranial inoculation route with PrPSc accumulation in CNS tissues, but prolonged incubation times and lack of PrPSc in lymphoid tissue.  相似文献   

10.
Mouse bioassay remains the gold standard for determining proof of infectivity, strain type, and infectious titer estimation in prion disease research. The development of an approach using ex vivo cell-based assays remains an attractive alternative, both in order to reduce the use of mice and to hasten results. The main limitation of a cell-based approach is the scarcity of cell lines permissive to infection with natural transmissible spongiform encephalopathy strains. This study combines two advances in this area, namely, the standard scrapie cell assay (SSCA) and the Rov9 and MovS6 cell lines, which both express the ovine PrP VRQ allele, to assess to what extent natural and experimental ovine scrapie can be detected ex vivo. Despite the Rov9 and MovS6 cell lines being of different biological origin, they were both permissive and resistant to infection with the same isolates of natural sheep scrapie as detected by SSCA. Rov9 subclones that are 20 times more sensitive than Rov9 to SSBP/1-like scrapie infection were isolated, but all the subclones maintained their resistance to isolates that failed to transmit to the parental line. The most sensitive subclone of the Rov9 cell line was used to estimate the infectious titer of a scrapie brain pool (RBP1) and proved to be more sensitive than the mouse bioassay using wild-type mice. Increasing the sensitivity of the Rov9 cell line to SSBP/1 infection did not correlate with broadening susceptibility, as the specificity of permissiveness and resistance to other scrapie isolates was maintained.Prion diseases are a group of neurodegenerative diseases affecting humans and animals, including scrapie in sheep and goats and bovine spongiform encephalopathy (BSE) in cattle. A feature of prion diseases and, in particular, of scrapie, is the existence of different strains (6) which influence pathology and is most probably related to the conformation of the pathogenic form of the prion protein (PrPSc). The susceptibility of sheep to scrapie is determined by the PrP genotype; codons 136, 154, and 171 determine relative resistance and susceptibility, with amino acids valine (V), arginine (R), and glutamine (Q) at these positions (known as VRQ) being considered the sheep PrP allele most susceptible to classical scrapie (3).An array of diagnostic tests exist for prion diseases, aimed at the detection of the disease-associated protease-resistant form of the naturally occurring PrPC protein, termed PrPSc or PrPres after partial protease digestion. However, the level of detectable PrPSc does not quantitatively correlate with prion infectivity (2) and the current biochemical analysis of PrPSc cannot always determine the strain (6, 7).Mouse bioassay remains the gold standard for determining proof of infectivity, strain type, and infectious titer estimate in ruminant transmissible spongiform encephalopathy (TSE) research. Conventional mouse bioassays using wild-type mice are generally slow (>150 days, and considerably longer, >600, days for obtaining infectious titer information) and require multiple mice to be dosed (typically 6 or more) at each dilution of infectious material. Therefore, the development of an approach using ex vivo cell-based assays remains an ethically and economically desirable alternative. Using cell lines permissive to mouse-passaged scrapie strains, Klöhn et al. have developed a cell-based assay for measuring de novo infection and the titer of mouse-passaged scrapie (18).The main limitation of adopting a cell-based approach is the scarcity of cell lines permissive to infection with natural TSE strains (for a review, see references 31 and 34), as the majority of permissive cell lines can only be infected with rodent-adapted strains of scrapie and BSE (4, 9, 16, 20, 23, 24, 29, 33, 36). While there are currently no cell lines reported to be permissive to bovine BSE or human TSE diseases, there are cell lines which express ovine PrP that have been shown to be permissive to natural scrapie infection (1, 35). There is also one fibroblast-like deer cell line that is able to propagate chronic wasting disease (27).Two of the sheep scrapie-susceptible cell lines are the MovS6 cell line (1), a Schwann cell line derived from the tg301 transgenic mouse, and the Rov9 cell line (35), based on a stably transfected rabbit kidney epithelial cell line (RK13) that does not express endogenous PrP. Both express the VRQ allele of ovine PrP, the latter upon induction with doxycycline (35). These cell lines were found to be permissive to infection with a PrP genotype-matched VRQ homozygous scrapie field case, and de novo PrPSc maintained its phenotype when used as an inoculum in mouse bioassays (1, 35). Using fluorescence-activated cell sorting, Falanga et al. isolated Rov9 subclones that produce higher levels of PrPC and PrPSc than the parental cell line when infected (11).The primary objective of this study was to assess the permissiveness of the Rov9 and MovS6 cell lines to a panel of scrapie isolates from a range of sheep breeds with a range of PrP genotypes. Second, subcloning of the Rov9 cell line was undertaken in an attempt to identify subclones with greater sensitivity and more diverse permissibility to ovine scrapie isolates.  相似文献   

11.

Background

It has been reported that cellular prion protein (PrPc) co-localizes with caveolin-1 and participates to signal transduction events by recruiting Fyn kinase. As PrPc is a secreted protein anchored to the outer surface membrane through a glycosylphosphatidylinositol (GPI) anchor (secPrP) and caveolin-1 is located in the inner leaflet of plasma membrane, there is a problem of how the two proteins can physically interact each other and transduce signals.

Results

By using the GST-fusion proteins system we observed that PrPc strongly interacts with caveolin-1 scaffolding domain and with a caveolin-1 hydrophilic C-terminal region, but not with the caveolin-1 N-terminal region. In vitro binding experiments were also performed to define the site(s) of PrPc interacting with cav-1. The results are consistent with a participation of PrPc octapeptide repeats motif in the binding to caveolin-1 scaffolding domain. The caveolar localization of PrPc was ascertained by co-immunoprecipitation, by co-localization after flotation in density gradients and by confocal microscopy analysis of PrPc and caveolin-1 distributions in a neuronal cell line (GN11) expressing caveolin-1 at high levels.

Conclusions

We observed that, after antibody-mediated cross-linking or copper treatment, PrPc was internalized probably into caveolae. We propose that following translocation from rafts to caveolae or caveolae-like domains, secPrP could interact with caveolin-1 and induce signal transduction events.
  相似文献   

12.
Ovine scrapie and cervine chronic wasting disease show considerable horizontal transmission. Here we report that a scrapie-affected sheep farm has a widespread environmental contamination with prions. Prions were amplified by protein-misfolding cyclic amplification (sPMCA) from seven of nine environmental swab samples taken, including those from metal, plastic, and wooden surfaces. Sheep had been removed from the areas from which the swabs were taken up to 20 days prior to sampling, indicating that prions persist for at least that long. These data implicate inanimate objects as environmental reservoirs for prion infectivity that are likely to contribute to facile disease transmission.Prion diseases are fatal neurological disorders. The archetypal prion disease is scrapie in sheep, and in the last few decades novel prion diseases have emerged in a range of species, including bovine spongiform encephalopathy (BSE) in cattle, chronic wasting disease (CWD) in deer, and variant Creutzfeldt-Jakob disease (vCJD) in humans. The “protein-only” hypothesis dictates that a pathological isoform, PrPSc, of the cellular prion protein (PrPC) constitutes the infectious agent, or prion (13). A wide range of tissues from CWD- and scrapie-affected animals contain PrPSc, and affected animals have been shown to excrete or secrete prions in milk, saliva, urine, and feces (2, 3, 6, 7, 8, 10, 16). This finding led to the hypothesis that infectivity resides in the environment, thus explaining the facile transmission of CWD and scrapie. In support of this hypothesis, CWD infectivity has been transmitted from a combination of exposed bedding, water, and food of captive animals (9), and CWD PrPSc has been detected within a single environmental water sample (11).Environmental prions are likely to be present at very low levels. The most sensitive method available for the detection of PrPSc is serial protein-misfolding cyclic amplification (sPMCA) (1). This technique was pioneered by Soto and colleagues (15), has been used for the amplification of scrapie (17), CWD (4), and vCJD (5) within their natural hosts, and has facilitated the detection of prions within ovine milk (6) and saliva (7) and within cervine urine (4). Here we investigated sources of environmental scrapie prions by applying sPMCA to samples taken from a range of surfaces that were accessible to animals on a farm where scrapie is endemic.Environmental samples were taken from the Veterinary Laboratories Agency, United Kingdom, farm where natural scrapie is endemic, with a high incidence since 1996. Sheep within the flock were exposed to the scrapie agent by natural routes of transmission. Control samples were taken from a farm (ADAS, United Kingdom) that houses a New Zealand-derived scrapie-free flock kept under strict biosecurity conditions. Environmental swabs were taken by wetting foam swabs (Edson Electronics, Northumberland, United Kingdom) in sterile water and then gently swabbing five times in both directions across a surface approximately 10 cm by 2 cm. Two swabs were taken from each area, and all samples were stored at −80°C. A total of nine environmental samples from a scrapie-affected farm and a scrapie-free farm were analyzed by sPMCA.Two swabs taken from each area were thawed to room temperature and placed in a single container to which 6 ml of 150 mM PO4 buffer plus 0.5% (vol/vol) Nonidet P-40 and 0.5% (wt/vol) sodium deoxycholate were added. The container was rotated for 2 h. Prions released into this buffer were precipitated on silicon dioxide and then eluted in 200 μl of 0.1% (wt/vol) sodium dodecyl sulfate. Ten microliters of the eluate was amplified within PCR tubes by sPMCA exactly as previously described (7). Samples from both a scrapie-exposed environment and a non-scrapie-exposed environment were analyzed concurrently within the same run on the same sonicator. Each extract was amplified at least in triplicate within a single run and then analyzed by Western blotting (14).Samples from four metal surfaces from an indoor pen occupied by sheep for a few days each week—a gate, a water trough, a feed trough, and penning—were analyzed. Samples from an outdoor environment that had contained sheep 20 days previously—a metal fence, a metal gate, a metal water trough, a plastic post where sheep frequently scratched, and a wooden fence post (Table (Table1)—were1)—were also analyzed. After 8 rounds of amplification, PrPSc was detected in all samples with the exceptions of the outdoor water trough and gate (Figure (Figure11 and Table Table1).1). Equivalent samples from a farm housing a scrapie-free flock were also analyzed, and PrPSc was not amplified even after 10 rounds of sPMCA. For indoor surfaces from the scrapie-affected farm, 83% of the sPMCA reactions were positive (n = 12), and 0% were positive for equivalent samples from a scrapie-free farm (n = 24). Similarly, 27% of analyses were positive for samples from outdoor surfaces (n = 15), and again no prion was amplified from equivalent samples taken from a scrapie-free farm (n = 30). For comparison of the percentages of positive sPMCA reactions for different cohorts of samples, data were set up as 2 by 2 contingency tables, and Fisher''s exact test (one-tailed) was applied to derive P values. Overall, prions were significantly more likely to be present in the scrapie-affected farm on indoor (P < 0.001) and outdoor (P = 0.009) surfaces. Analyses of all samples were carried out in two independent experiments that gave equivalent results.Open in a separate windowFIG. 1.Amplification of prions from environmental samples. Prions were extracted from swabs taken of surfaces from a scrapie-free farm or a farm where scrapie is endemic. Swabs were taken from a wooden post (1), a plastic scratching post (2), and the following metal surfaces: fencing (3), gate (4 and 6), pen (5), feed trough (7), and water trough (8 and 9). Samples 1, 2, 3, 4, and 8 were taken from outdoor surfaces and 5, 6, 7, and 9 from indoor surfaces. Extracts were used as seeds for 8 rounds of sPMCA. Products were digested with proteinase K and analyzed by Western blotting. PrP was detected with monoclonal antibodies SHA31 and P4. Molecular-weight markers are shown.

TABLE 1.

sPMCA of prions found in the environmenta
Source of samplebNo. of positive tests/no. of total tests for samples from a farm where scrapie is endemicPMCA roundc that yielded PrPScNo. of positive tests/no. of total tests for samples from a scrapie-free farm
Indoor environment
    Metal water trough2/370/6
    Metal gate3/360/6
    Metal penning3/360/6
    Metal feed trough2/360/6
Outdoor environment
    Metal water trough0/3n/a0/6
    Metal gate0/3n/a0/6
    Metal fencing1/370/6
    Plastic scratching post2/380/6
    Wooden fence post1/370/6
Open in a separate windowaSamples were taken from a farm where scrapie is endemic and one that is scrapie free and were subjected to 8 rounds of sPMCA.bMetal surfaces were zinc-galvanized steel.cEarliest round that yielded detectable proteinase K-resistant PrPSc from each scrapie-exposed sample. n/a, not applicable.The extracts from environmental swabs became positive for PrPSc after 6 to 8 rounds of PMCA (Table (Table1).1). In order to estimate the levels of prions within these extracts, the limit of detection of the amplification methodology was estimated by spiking a 10-fold dilution series of brain stem homogenate from a scrapie-affected sheep into the PMCA reaction. Following 6 rounds of amplification, PrPSc could be detected in extracts containing 1 ×10−11 g of brain material. The levels of total PrP and protease-resistant PrP within the brain material were estimated by enzyme-linked immunosorbent assay (ELISA) against a recombinant PrP standard curve, and the levels within 1 ×10−11 g of brain material equated to 0.24 ×10−15 g of protease-resistant PrPSc and 0.4 × 10−15 g of total PrP. A similar level of amplification was achieved from a one-tenth volume of a swab extract. These data indicate that a swab extract taken from a 20-cm2 area of a farm surface contains approximately 2.4 ×10−15 g of protease-resistant PrPSc and 4 × 10−15 g of total PrP.These data indicate that surfaces exposed to scrapie-infected animals can act as reservoirs of PrPSc and therefore have the potential to facilitate disease transmission. Prions were eluted from surfaces upon brief contact, indicating their availability for uptake by sheep through ingestion and/or skin scarification. Given the striking similarities between CWD and scrapie with regard to widespread in vivo prion dissemination, secretion of the disease agent, and facile disease transmission, it seems extremely likely that inanimate objects also serve as environmental reservoirs for CWD for both farmed and wildlife populations. For scrapie and CWD, it is likely that the widespread in vivo dissemination of infectivity facilitates the secretion and/or excretion of prions into the environment. It seems unlikely that most human prion diseases and BSE in cattle would display analogous excretion of prions, as there is limited in vivo spread of the infectious agent. However, vCJD, the human form of BSE, has widespread in vivo PrPSc, similar to CWD and scrapie (12). As data indicate that the causal agents of CWD (9, 11) and scrapie are maintained within the environment on a range of fomites, it should be a priority to determine whether vCJD prions follow similar dissemination routes.The findings of the present study may well have a considerable impact on the understanding of the horizontal transmission of both scrapie and CWD and therefore on the management of farmed animals. The level of prions found on 20-cm2 surfaces was similar to that detected in a milliliter of urine from scrapie-affected hamsters (2), a volume known to contain infectivity (3). However, at present it has not been confirmed that the low levels of prions on environmental surfaces are sufficient to cause disease in exposed sheep. As a first step in determining whether such prions are indeed capable of transmitting disease in sheep, the concentrated extracts of the swabs will be inoculated into transgenic mice in order to determine the presence of infectivity.  相似文献   

13.

Background

Transmissible agents involved in prion diseases differ in their capacities to target different regions of the central nervous system and lymphoid tissues, which are also host-dependent.

Methodology/Principal Findings

Protease-resistant prion protein (PrPres) was analysed by Western blot in the spleen of transgenic mice (TgOvPrP4) that express the ovine prion protein under the control of the neuron-specific enolase promoter, after infection by intra-cerebral route with a variety of transmissible spongiform encephalopathies (TSEs) from cattle and small ruminants. Splenic PrPres was consistently detected in classical BSE and in most natural scrapie sources, the electrophoretic pattern showing similar features to that of cerebral PrPres. However splenic PrPres was not detected in L-type BSE and TME-in-cattle, or in the CH1641 experimental scrapie isolate, indicating that some TSE strains showed reduced splenotropism in the ovine transgenic mice. In contrast with CH1641, PrPres was also consistently detected in the spleen of mice infected with six natural “CH1641-like” scrapie isolates, but then showed clearly different molecular features from those identified in the brains (unglycosylated PrPres at ∼18 kDa with removal of the 12B2 epitope) of ovine transgenic mice or of sheep. These features included different cleavage of the main PrPres cleavage product (unglycosylated PrPres at ∼19 kDa with preservation of the 12B2 epitope) and absence of the additional C-terminally cleaved PrPres product (unglycosylated form at ∼14 kDa) that was detected in the brain.

Conclusion/Significance

Studies in a transgenic mouse model expressing the sheep prion protein revealed different capacities of ruminant prions to propagate in the spleen. They showed unexpected features in “CH1641-like” ovine scrapie suggesting that such isolates contain mixed conformers with distinct capacities to propagate in the brain or lymphoid tissues of these mice.  相似文献   

14.

Background

Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare neurodegenerative disorder in humans included in the group of Transmissible Spongiform Encephalopathies or prion diseases. The vast majority of sCJD cases are molecularly classified according to the abnormal prion protein (PrPSc) conformations along with polymorphism of codon 129 of the PRNP gene. Recently, a novel human disease, termed "protease-sensitive prionopathy", has been described. This disease shows a distinct clinical and neuropathological phenotype and it is associated to an abnormal prion protein more sensitive to protease digestion.

Case presentation

We report the case of a 75-year-old-man who developed a clinical course and presented pathologic lesions compatible with sporadic Creutzfeldt-Jakob disease, and biochemical findings reminiscent of "protease-sensitive prionopathy". Neuropathological examinations revealed spongiform change mainly affecting the cerebral cortex, putamen/globus pallidus and thalamus, accompanied by mild astrocytosis and microgliosis, with slight involvement of the cerebellum. Confluent vacuoles were absent. Diffuse synaptic PrP deposits in these regions were largely removed following proteinase treatment. PrP deposition, as revealed with 3F4 and 1E4 antibodies, was markedly sensitive to pre-treatment with proteinase K. Molecular analysis of PrPSc showed an abnormal prion protein more sensitive to proteinase K digestion, with a five-band pattern of 28, 24, 21, 19, and 16 kDa, and three aglycosylated isoforms of 19, 16 and 6 kDa. This PrPSc was estimated to be 80% susceptible to digestion while the pathogenic prion protein associated with classical forms of sporadic Creutzfeldt-Jakob disease were only 2% (type VV2) and 23% (type MM1) susceptible. No mutations in the PRNP gene were found and genotype for codon 129 was heterozygous methionine/valine.

Conclusions

A novel form of human disease with abnormal prion protein sensitive to protease and MV at codon 129 was described. Although clinical signs were compatible with sporadic Creutzfeldt-Jakob disease, the molecular subtype with the abnormal prion protein isoforms showing enhanced protease sensitivity was reminiscent of the "protease-sensitive prionopathy". It remains to be established whether the differences found between the latter and this case are due to the polymorphism at codon 129. Different degrees of proteinase K susceptibility were easily determined with the chemical polymer detection system which could help to detect proteinase-susceptible pathologic prion protein in diseases other than the classical ones.
  相似文献   

15.

Background

So-called atypical scrapie was first identified in Great Britain (GB) in 2002 following the introduction of wide-scale scrapie surveillance. In particular, abattoir and fallen stock surveys have been carried out in GB since 2002, with a total of 147 atypical positives identified by the end of 2006. The results of these surveys provide data with which to assess temporal trends in the prevalence of atypical scrapie in sheep in Great Britain between 2002 and 2006.

Results

Using the results of abattoir and fallen stock surveys, the prevalence of atypical scrapie (percentage of samples positive) was estimated. The prevalence in the abattoir and fallen stock surveys, for all years combined, was 0.09% (95% confidence interval (CI): 0.08%–0.11%) and 0.07% (95% CI: 0.05%–0.11%), respectively. There were no significant temporal trends in either survey. Comparing the surveys' results, there were no significant differences in annual prevalence or the prevalence within PrP genotypes. For the abattoir survey, the PrP genotype with the highest prevalence was AHQ/AHQ, which was significantly higher than all other genotypes, except ARR/AHQ, AHQ/ARH and ARH/ARQ.

Conclusion

The estimated prevalence of atypical scrapie was similar in both the abattoir and fallen stock surveys. Our results indicate there was no significant temporal trend in prevalence, adding to evidence that this atypical form of scrapie may be a sporadic condition or, if it is infectious, that the force of infection is very low.
  相似文献   

16.
17.
Since prion infectivity had never been reported in milk, dairy products originating from transmissible spongiform encephalopathy (TSE)-affected ruminant flocks currently enter unrestricted into the animal and human food chain. However, a recently published study brought the first evidence of the presence of prions in mammary secretions from scrapie-affected ewes. Here we report the detection of consistent levels of infectivity in colostrum and milk from sheep incubating natural scrapie, several months prior to clinical onset. Additionally, abnormal PrP was detected, by immunohistochemistry and PET blot, in lacteal ducts and mammary acini. This PrPSc accumulation was detected only in ewes harbouring mammary ectopic lymphoid follicles that developed consequent to Maedi lentivirus infection. However, bioassay revealed that prion infectivity was present in milk and colostrum, not only from ewes with such lympho-proliferative chronic mastitis, but also from those displaying lesion-free mammary glands. In milk and colostrum, infectivity could be recovered in the cellular, cream, and casein-whey fractions. In our samples, using a Tg 338 mouse model, the highest per ml infectious titre measured was found to be equivalent to that contained in 6 µg of a posterior brain stem from a terminally scrapie-affected ewe. These findings indicate that both colostrum and milk from small ruminants incubating TSE could contribute to the animal TSE transmission process, either directly or through the presence of milk-derived material in animal feedstuffs. It also raises some concern with regard to the risk to humans of TSE exposure associated with milk products from ovine and other TSE-susceptible dairy species.  相似文献   

18.
Abnormalities in Stress Proteins in Prion Diseases   总被引:1,自引:0,他引:1  
1. Prion diseases include kuru, Creutzfeldt–Jakob disease (CJD), Gerstmann–Sträussler–Scheinker disease (GSS), and fatal familia insomnia (FFI) of humans, as well as scrapie and bovine spongiform encephalopathy (BSE) of animals.2. All these disorders involve conversion of the normal, cellular prion protein (PrPC) into the corresponding scrapie isoform (PrPSc). PrPC adopts a structure rich in -helices and devoid of -sheet, in contrast to PrPSc, which has a high -sheet content and is resistant to limited digestion by proteases. That a conformational transition features in the conversion of PrPC into PrPSc implies that prion diseases are disorders of protein conformation.3. This concept has been extended by our studies with heat shock proteins (Hsp), many of which are thought to function as molecular chaperones. We found that the induction of some Hsps but not others was profoundly altered in scrapie-infected cells and that the distribution of Hsp73 is unusual in these cells.4. Whether the conversion of PrPC into PrPSc is assisted by molecular chaperones, or if the accumulation of the abnormally folded PrPSc is complexed with Hsps remains to be established.  相似文献   

19.

Background

Prions, infectious agents associated with prion diseases such as Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy (BSE) in cattle, and scrapie in sheep and goats, are primarily comprised of PrPSc, a protease-resistant misfolded isoform of the cellular prion protein PrPC. Protein misfolding cyclic amplification (PMCA) is a highly sensitive technique used to detect minute amounts of scrapie PrPSc. However, the current PMCA technique has been unsuccessful in achieving good amplification in cattle. The detailed distribution of PrPSc in BSE-affected cattle therefore remains unknown.

Methodology/Principal Findings

We report here that PrPSc derived from BSE-affected cattle can be amplified ultra-efficiently by PMCA in the presence of sulfated dextran compounds. This method is capable of amplifying very small amounts of PrPSc from the saliva, palatine tonsils, lymph nodes, ileocecal region, and muscular tissues of BSE-affected cattle. Individual differences in the distribution of PrPSc in spleen and cerebrospinal fluid samples were observed in terminal-stage animals. However, the presence of PrPSc in blood was not substantiated in the BSE-affected cattle examined.

Conclusions/Significance

The distribution of PrPSc is not restricted to the nervous system and can spread to peripheral tissues in the terminal disease stage. The finding that PrPSc could be amplified in the saliva of an asymptomatic animal suggests a potential usefulness of this technique for BSE diagnosis. This highly sensitive method also has other practical applications, including safety evaluation or safety assurance of products and byproducts manufactured from bovine source materials.  相似文献   

20.
Species, as well as individuals within species, have unique susceptibilities to prion infection that are likely based on sequence differences in cellular prion protein (PrPC). Species barriers to transmission also reflect PrPC sequence differences. Defining the structure-activity relationship of PrPC/PrPSc with respect to infectivity/susceptibility will benefit disease understanding and assessment of transmission risks. Here, nanopore analysis is employed to investigate genotypes of sheep PrPC corresponding to differential susceptibilities to scrapie infection. Under non-denaturing conditions scrapie resistant (ARR) and susceptible (VRQ) genotypes display similar, type I (bumping) predominant event profiles, suggesting a conserved folding pattern. Under increasingly denaturing conditions both proteins shift to type II (intercalation/translocation) events but with different sensitivities to unfolding. Specifically, when pre-incubated in 2M Gdn-HCl, the VRQ variant had more of type II events as compared with the ARR protein, suggesting a more flexible unfolding pattern. Addition of PrPSc-specific polyclonal antibody (YML) to the ARR variant, pre-incubated in 2M Gdn-HCl, reduced the number of type II events with no clear intercalation/translocation peak, whereas for VRQ, type II events above blockades of 90 pA bound YML. A second PrPSc-specific antibody (SN6b) to a different cryptic epitope reduced type II events for VRQ but not the ARR variant. Collectively, the event patterns associated with sequential denaturation, as well as interactions with PrPSc-specific antibodies, support unique patterns and/or propensities of misfolding between the genotypes. Overall, nanopore analysis identifies intermediate conformations that occur during the unfolding pathways of ARR and VRQ genotypes and may help to understand the correlation of structural properties that induce protein misfolding.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号